Actavis Inc recalls Albuterol Sulfate Inhalation Solution, USP, 0.021% (0.63 mg / 3 mL), 3mL Vials, Rx only, Mfd. for Watson Laboratories In
Recalled February 1, 2017 · FDA recall D-0439-2017 · Actavis
Hazard
Failed Impurities/Degradation Specifications: Product is out of specification for a known degradant. · FDA Class III
Units
164,844 units
Sold at
Nationwide in the US
Description
Failed Impurities/Degradation Specifications: Product is out of specification for a known degradant.
Product
Albuterol Sulfate Inhalation Solution, USP, 0.021% (0.63 mg / 3 mL), 3mL Vials, Rx only, Mfd. for Watson Laboratories Inc., Corona, CA 92880 USA, Mfd. by Cipla Ltd. Verna, Goa India, NDC 0591-3467-53
Manufacturer(s)
Actavis Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →